Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 225 of 741 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/18
End: 10/30/20
Due: 10/30/21
Phase: N/A
Priority: Normal
Start: 01/31/08
End: 12/31/12
Due: 12/31/13
Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Phase: N/A
Priority: Normal
Start: 01/10/08
End: 01/10/21
Due: 01/10/22
Phase: N/A
Priority: Normal
Start: 11/01/22
End: 03/01/23
Due: 03/01/24
Phase: N/A
Priority: Normal
Start: 07/01/25
End: 01/30/26
Due: 01/30/27
Phase: N/A
Priority: Normal
Start: 04/13/21
End: 11/22/23
Due: 11/22/24
Phase: N/A
Priority: Normal
Start: 03/07/25
End: 08/31/26
Due: 08/31/27
Phase: N/A
Priority: Normal
Start: 01/31/05
End: 04/30/06
Due: 04/30/07
Phase: N/A
Priority: Normal
Start: 06/04/25
End: 06/30/28
Due: 06/30/29
Phase: N/A
Priority: Normal
Start: 07/07/16
End: 07/05/18
Due: 07/05/19
Phase: N/A
Priority: Normal
Start: 03/31/12
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 12/31/20
End: 07/31/23
Due: 07/31/24
Phase: N/A
Priority: Normal
Start: 01/13/17
End: 09/30/25
Due: 09/30/26
Phase: N/A
Priority: Normal
Start: 02/22/17
End: 06/20/18
Due: 06/20/19
Phase: N/A
Priority: Normal
Start: 02/16/14
End: 11/30/16
Due: 11/30/17
Phase: N/A
Priority: Normal
Start: 01/01/16
End: 04/30/18
Due: 04/30/19
Phase: N/A
Priority: Normal
Start: 09/30/96
End: 07/31/00
Due: 07/31/01
Phase: N/A
Priority: Normal
Start: 11/23/21
End: 02/28/25
Due: 02/28/26
Phase: N/A
Priority: Normal
Start: 09/11/22
End: 10/01/27
Due: 10/01/28
Phase: N/A
Priority: Normal
Start: 09/01/23
End: 09/01/27
Due: 09/01/28
Phase: N/A
Priority: Normal
Start: 01/01/22
End: 05/05/24
Due: 05/05/25
Phase: N/A
Priority: Normal
Start: 07/13/16
End: 02/17/17
Due: 02/17/18
Phase: N/A
Priority: Normal
Start: 05/01/22
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 11/01/25
End: 08/31/28
Due: 08/31/29
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 12/31/08
Due: 12/31/09